Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors

Abstract Background We developed a novel risk scoring system for urothelial cancer (UC) patients receiving immune checkpoint inhibitors (ICI). Methods We conducted a retrospective review of 67 UC patients treated with ICI at Winship Cancer Institute of Emory University from 2015 to 2018. Using stepw...

Full description

Bibliographic Details
Main Authors: Julie M. Shabto, Dylan J. Martini, Yuan Liu, Deepak Ravindranathan, Jacqueline Brown, Emilie E. Hitron, Greta A. Russler, Sarah Caulfield, Haydn Kissick, Mehrdad Alemozaffar, Kenneth Ogan, Wayne B. Harris, Viraj A. Master, Omer Kucuk, Bradley C. Carthon, Mehmet A. Bilen
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Cancer Medicine
Subjects:
cancer risk factors
immunology
risk assessment
urological oncology
Online Access:https://doi.org/10.1002/cam4.2932

Internet

https://doi.org/10.1002/cam4.2932

Similar Items